MarketInOut Stock Screener Log In | Sign Up
 

Enovis Corp

NYSE • Healthcare • Medical Devices • Quote as of 05/08/2026 16:00
Enovis Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization1,531.11 mln
Float56.74 mln
Earnings Date07/30/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.94
Likely reliable

1-Year Forecast

44.27
Transformational upside

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.93
Moderate leverage

ROE

-52.56
Deeply negative

Business Description

Enovis Corporation is a medical technology company based in Wilmington, Delaware, that develops and sells products designed to help patients recover from and manage musculoskeletal conditions. The company serves two broad areas: non-surgical tools such as braces, therapy systems, and pain management devices used by a wide range of healthcare providers, and surgical solutions including joint replacement implants and related instruments for procedures involving the hip, knee, shoulder, and other joints. Its products reach patients through a network of direct sales staff and independent distributors across the United States and internationally. Originally founded in 1995 as Colfax Corporation, the company rebranded as Enovis to better reflect its focus on improving patient mobility and outcomes.

Key Fundamentals

EPS-19.89
ROE-52.56
RPS39.39
ROIC-0.45
ROA-25.88
EBITDA, mln-830
EV / EBITDA-3.59
EV / EBIT-2.65
Revenue, mln2,248
EV / Revenue1.33

Financial Strength

Altman Z-Score-0.38
Piotroski F-Score 4 / 9
Beneish M-Score-2.94
Price to Intrinsic Value0.94
1-Year Target Price44.27
Short Ratio11.60
Short % of Float17.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.28% 92 / 100   
1 Month 10.5% 75 / 100   
2 Months 20.33% 86 / 100   
6 Months -15.78% 26 / 100   
1 Year -22.55% 20 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us